Cat. No. | Product name | CAS No. |
DC9936 |
NMS-P118
Featured
NMS-P118 is a potent, orally available, and highly selective PARP-1 inhibitor with excellent ADME and pharmacokinetic profiles and high efficacy in vivo. |
1262417-51-5 |
DC8178 |
Beclabuvir(BMS-791325)
non-nucleoside inhibitor of the NS5B |
958002-33-0 |
DC8583 |
Asenapine Maleate
Featured
Novel psychopharmacologic agent. Displays antagonist activity at 5-HT, dopamine, noradrenalin and histamine receptor subtypes (pKi values are 8.60, 8.40, 10.15, 9.75, 10.46, 8.84, 9.60, 9.94, 8.85, 8.90, 8.84, 9.38, 8.95, 8.93, 8.9, 9.49, 8.91, 9.00 and 8 |
85650-56-2 |
DC4136 |
NPS-2143 HCL
NPS 2143 hydrochloride is a selective CaSR (Ca2+-sensing receptor) inhibitor and antagonist, shown to block increases in cytoplasmic Ca2+ concentrations elicited by human Ca2+ receptors expressed in HEK293 cells with an IC50 of 43 nM. NPS 2143 hydrochlori |
324523-20-8 |
DC7214 |
NPS-2143(SB 262470A )
NPS-2143(SB 262470A ) is a selective potent calcium ion-sensing receptor antagonist with IC50 of 43 and 41 nM for cytoplasmic Ca2+ concentrations and parathyroid hormone secretion, respectively. |
284035-33-2 |
DC8183 |
Paritaprevir(Veruprevir ABT-450)
Featured
NS3/4A protease inhibitor |
1216941-48-8 |
DC9486 |
Nucleozin
Featured
Nucleozin targets influenza A nucleoprotein (NP), a multifunctional, RNA-binding protein necessary for virus replication. |
341001-38-5 |
DC4174 |
NVP-AEW541
Featured
NVP-AEW541 is a potent inhibitor of IGF-1R with IC50 of 86 nM. |
475489-16-8 |
DC4118 |
NVP-BEP800
Featured
NVP-BEP800 is a novel, fully synthetic HSP90β inhibitor with IC50 of 58 nM. |
847559-80-2 |
DC3133 |
NVP-BGT226 (BGT226)
Featured
NVP-BGT226 is a novel dual PI3K/mTOR inhibitor with IC50 of 1 nM. |
1245537-68-1 |
DC7303 |
NVP-TAE684
Featured
NVP-TAE684(TAE684) is a highly potent and selective small-molecule ALK inhibitor, which blocked the growth of ALCL-derived and ALK-dependent cell lines with IC50 values between 2 and 10 nM. |
761439-42-3 |
DC4237 |
NXY-059 (Cerovive)
NXY-059 (Cerovive) is an EGFR and HER2 autophosphorylation inhibitor, against purified EGFR and HER2 of 10.2 and 9.8 nM, respectively. |
168021-79-2 |
DC10807 |
O304
Featured
O304 is a novel AMPK activator. |
1261289-04-6 |
DC10134 |
Obicetrapib (AMG-899,TA-8995)
Featured
Obicetrapib is a CETP inhibitor, on the elevation of high-density lipoprotein cholesterol (HDL-C) and reduction of low-density lipoprotein cholesterol (LDL-C), alone and in combination with statin therapy. |
866399-87-3 |
DC12298 |
Octreotide acetate (SMS 201-995 (acetate))
Featured
Octreotide acetate, a long-acting synthetic analog of native somatostatin, inhibits growth hormone, glucagon, and insulin more potently. |
79517-01-4 |
DC6401 |
Odanacatib (MK 0822)
Featured
Odanacatib (MK 0822) is a potent, selective, and neutral inhibitor of human and rabbit cathepsin K with IC50 of 0.2 nM and 1 nM , respectively. |
603139-19-1 |
DC8700 |
ODM-201(Darolutamide)
Featured
ODM-201 is a potent and full antagonists for human AR (hAR) with IC50 values of 26 nM by transactivation assays in AR-HEK293 cells. |
1297538-32-9 |
DC9583 |
Oglemilast
Oglemilast(GRC3886) is a potent PDE4 inhibitor, under clinical studies in the treatment of allergen-induced asthma. |
778576-62-8 |
DC11096 |
Olacaftor
Olacaftor (VX-440, VX440) is a next-generation CFTR corrector, showsthe potential to enhance the amount of CFTR protein at the cell’s surface and for treatment of cystic fibrosis.. |
1897384-89-2 |
DC4110 |
AZD-2281 (Olaparib)
Featured
Olaparib (AZD2281, KU0059436) is a selective inhibitor of PARP1 and PARP2 with IC50 of 5 nM and 1 nM, respectively. |
763113-22-0 |
DCAPI1464 |
Olmesartan
Olmesartan Acid is an angiotensin II receptor antagonist that prevents the binding of angiotensin II, thus preventing vasoconstriction. |
144689-24-7 |
DC9179 |
Olmesartan MedoxoMil
Olmesartan medoxomil(Olmetec; Benicar; CS 866) is an angiotensin II receptor antagonist which is used as an anti-hypertensive. |
144689-63-4 |